Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Xeris Biopharma Holdings (XERS) Shares Issued: 2021-2025

Historic Shares Issued for Xeris Biopharma Holdings (XERS) over the last 2 years, with Sep 2025 value amounting to $5.2 million.

  • Xeris Biopharma Holdings' Shares Issued was N/A to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 126.59% up from last year.
  • Latest data reveals that Xeris Biopharma Holdings reported Shares Issued of $5.2 million as of Q3 2025, which was up 430.97% from $972,000 recorded in Q2 2025.
  • Over the past 5 years, Xeris Biopharma Holdings' Shares Issued peaked at $30.0 million during Q1 2022, and registered a low of $251,000 during Q2 2024.
  • Over the past 3 years, Xeris Biopharma Holdings' median Shares Issued value was $549,000 (recorded in 2023), while the average stood at $1.8 million.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Shares Issued tumbled by 54.28% in 2024 and then skyrocketed by 959.04% in 2025.
  • Over the past 5 years, Xeris Biopharma Holdings' Shares Issued (Quarterly) stood at $27.0 million in 2021, then climbed by 11.11% to $30.0 million in 2022, then reached $549,000 in 2023, then slumped by 54.28% to $534,000 in 2024, then surged by 287.25% to $5.2 million in 2025.
  • Its last three reported values are $5.2 million in Q3 2025, $972,000 for Q2 2025, and $4.9 million during Q1 2025.